Showing 1541-1550 of 2157 results for "".
- Calling All Researchers: ProofPilot Is Seeking Research Ideas on Issues Concerning BIPOC Communitieshttps://modernaesthetics.com/news/calling-all-researchers-proofpilot-is-seeking-research-ideas-on-issues-concerning-bipoc-communities/2473253/ProofPilot, a Software as a Service (SaaS) clinical trial research platform, is rolling out its first ever Open Invitation for Research in partnership with the nonprofit organization
- Colorescience Finishing Touch Protocol Boosts Patient Satisfaction after Microneedling RFhttps://modernaesthetics.com/news/colorescience-finishing-touch-protocol-boosts-patient-satisfaction-after-microneedling-rf/2473243/Colorescience’s Finishing Touch post-treatment skincare protocol improves patient confidence, comfort, satisfaction, and increases the likelihood of a repeat radiofrequency microneedling procedure, according to research in The Journal of Clinical and Aesthetic Dermatology
- Bellafill Marks Distribution of 1 Million Syringeshttps://modernaesthetics.com/news/bellafill-marks-distribution-of-1-million-syringes/2473197/At the close of 2021,
- Business News: $511M SPAC Merger Deal for Sunevahttps://modernaesthetics.com/news/business-news-511m-spac-merger-deal-for-suneva/2473182/Suneva Medical, Inc. and Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), are joining forces to form a regenerative aesthetics company. Upon completion of the transaction, the combined company's securities are expected to be traded on the NYSE unde
- Placental Allograft Technology from MiMedx Shown Beneficial for Mohs Repairshttps://modernaesthetics.com/news/placental-allograft-technology-from-mimedx-shown-beneficial-for-mohs-repairs/2473174/MiMedx Group’s Purion® processed dHACM (Epifix®) placental allografts are associated with a statistically significant lower risk for infection, poor scar cosmesis, scar revision, and additional operation at the index site, when compared to traditional methods of incisional repair po
- Alastin Receives Two New Patents for Technology Related to TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-receives-two-new-patents-for-technology-related-to-transform-body-treatment/2473148/With the issuance of two new patents from the United States Patent and Trademark Office, Alastin Skincare, Inc. now holds six patents in the US, along with a seventh patent issued in Canada. US Patent No.11,052,032 covers Alastin’s
- Allergan to Buy Soliton and Resonic, Its Rapid Acoustic Pulse Devicehttps://modernaesthetics.com/news/allergan-to-buy-soliton/2473103/Allergan Aesthetics is set to acquire Soliton and Resonic, its Rapid Acoustic Pulse device. Resonic recently received U.S. Food and Drug Administration (FDA) 510(k) clearance and is a non-invasive treatment for the short-term improvement in the appearance of cellulite. The acquisition o
- Cynosure to Buy MyEllevate Surgical Suture Systemhttps://modernaesthetics.com/news/cynosure-to-buy-myellevate-surgical-suture-system/2473098/Cynosure is acquiring the MyEllevate Surgical Suture System, which allows practitioners to place a suture support system without incisions. MyEllevate, performed with the ICLED light-guided suture system, is the first and only patented light-guided technology for use in soft tissue
- First, Do No Harm: American Board of Cosmetic Surgery Announces New Cosmetic Surgery Patient Safety Certification Programhttps://modernaesthetics.com/news/first-do-no-harm-american-board-of-cosmetic-surgery-announces-new-cosmetic-surgery-patient-safety-certification-program/2473072/The
- Allergan Donates $300K to Bridge the Gender Gap in STEMhttps://modernaesthetics.com/news/allergan-donates-300k-to-bridge-the-gender-gap-in-stem/2472964/Allergan has pledged $300K to support STEM Education through their partnership with Girls Inc. In addition to the donation, Allergan is also offering mentoring initiatives and resources to educate and empower future female leaders interest